Effect of Momordica charantia Administration on Anthropometric Measures and Metabolic Profile in Patients with Obesity: A Pilot Clinical Trial
Cortez-Navarrete M, Méndez-Del Villar M, Martínez-Abundis E, López-Murillo LD, Escobedo-Gutiérrez MJ
Published in Journal of Medicinal Food
Methodology
Randomized, double-blind, placebo-controlled pilot trial of 2000 mg/day Momordica charantia for 12 weeks in patients with obesity.
Key Findings
No significant reductions in body weight, BMI, waist circumference or body fat; significant decreases in triglycerides and VLDL.
Conclusions
Bitter melon did not reduce body weight or fat in obesity, though it lowered triglycerides and VLDL.
Limitations
Pilot size (n=24), short duration, placebo group gained weight.
Supplements Studied
no significant reductions in BW, BMI, WC, and body fat percentage were observed after MC administration; however, MC significantly decreased TG and VLDL levels
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.